Serotonin Reuptake Inhibitor class drugs

13 results
  • fluoxetine

    (Fluoxetine Hydrochloride)
    Aurobindo Pharma Limited
    Fluoxetine capsules are indicated for the treatment of Major Depressive Disorder, Obsessive Compulsive Disorder, Bulimia Nervosa, and Panic Disorder. In combination with Olanzapine, they also treat depressive episodes in Bipolar I Disorder and treatment-resistant depression. Monotherapy with fluoxetine is not approved for Bipolar I or treatment-resistant depression.
  • fluoxetine

    (Fluoxetine Hydrochloride)
    ScieGen Pharmaceuticals, Inc.
    Fluoxetine is indicated for the treatment of Major Depressive Disorder, Obsessive Compulsive Disorder, Bulimia Nervosa, and Panic Disorder. In combination with Olanzapine, it is used for depressive episodes in Bipolar I Disorder and treatment-resistant depression. Monotherapy with fluoxetine is not suitable for these latter conditions.
  • fluoxetine hydrochloride

    (Fluoxetine Hydrochloride)
    ANI Pharmaceuticals, Inc.
    Fluoxetine is indicated for the acute and maintenance treatment of Major Depressive Disorder, Obsessive Compulsive Disorder, Bulimia Nervosa, and Panic Disorder. It is not approved for Bipolar I Disorder depressive episodes or treatment-resistant depression.
  • fluvoxamine maleate

    (Fluvoxamine maleate)
    Upsher-Smith Laboratories, LLC
    Fluvoxamine maleate tablets are indicated for treating obsessive-compulsive disorder (OCD), addressing distressing obsessions and compulsions that interfere with daily functioning. Efficacy has been established through multiple clinical trials in both adult and pediatric populations.
  • fluvoxamine maleate

    (Fluvoxamine Maleate)
    Ajanta Pharma USA Inc.
    Fluvoxamine maleate extended-release capsules are indicated for treating obsessive-compulsive disorder (OCD) in adults and children (ages 8-17). The drug addresses recurrent, distressing obsessions and compulsions that interfere with daily functioning, evidenced by clinical trials demonstrating efficacy over both short and long-term use.
  • lexapro

    (ESCITALOPRAM)
    Allergan, Inc.
    Lexapro is indicated for treating major depressive disorder (MDD) in adults and pediatric patients aged 12 and older, as well as generalized anxiety disorder (GAD) in adults and pediatric patients aged 7 and older.
  • paroxetine

    (PAROXETINE)
    Chartwell RX, LLC.
    Paroxetine is indicated for the treatment of major depressive disorder, obsessive-compulsive disorder, panic disorder, social anxiety disorder, generalized anxiety disorder, and posttraumatic stress disorder in adults.
  • paroxetine

    (Paroxetine)
    Yiling Pharmaceutical, Inc.
    Paroxetine is indicated for treating major depressive disorder, obsessive compulsive disorder, panic disorder, social anxiety disorder, generalized anxiety disorder, and posttraumatic stress disorder in adults.
  • prozac

    (Fluoxetine hydrochloride)
    Dista Products Company
    PROZAC® is indicated for the treatment of Major Depressive Disorder, Obsessive Compulsive Disorder, Bulimia Nervosa, and Panic Disorder. It is also used in combination with Olanzapine for Bipolar I Disorder and treatment-resistant depression in patients unresponsive to previous antidepressants.
  • sertraline hydrochloride

    (SERTRALINE HYDROCHLORIDE)
    Accord Healthcare, Inc.
    Sertraline hydrochloride is indicated for treating major depressive disorder, obsessive-compulsive disorder, panic disorder, posttraumatic stress disorder, social anxiety disorder, and premenstrual dysphoric disorder.